Released September 08, 2021 | BEIJING
en
Researched by Industrial Info Resources (Sugar Land, Texas)--The global pharmaceutical intermediates market was valued at about $1.3 trillion in 2020, of which $33 billion was attributed to China. By the end of 2021, China's pharmaceutical intermediates market is expected to reach $35 billion.
Industrial Info is tracking 98 active pharmaceutical intermediates projects across China, totaling more than $4.3 billion of investment. Subscribers to Industrial Info's Global Market Intelligence (GMI) Pharmaceutical & Biotech Project Database can click here for a list of related projects.
Click on the image at right for a heat map of China's active pharmaceutical intermediates projects, from Industrial Info's Geolocator tool.
Zhejiang Jiuzhou Pharmaceutical Company Limited accounts for more investment than any other company, with more than $246 million from two projects. Most of China's pharmaceutical intermediates manufacturing companies are located in the Jiangsu and Zhejiang provinces, particularly in the cities of Taizhou and Jintan, due to preferential tax policies and support from local civic leaders.
Other key players in the China intermediates market include Zhejiang Longsheng Group Company Limited, Nantong Acetic Acid Chemical Company Limited, Apeloa Pharmaceutical Company Limited, Shandong Sinobioway Biomedicine Company Limited and Zhe Jiang Hua Hai Pharmaceutical Company Limited.
Industrial Info Resources (IIR), with global headquarters in Sugar Land, Texas, six offices in North America and 12 international offices, is the leading provider of global market intelligence specializing in the industrial process, heavy manufacturing and energy markets. Industrial Info's quality-assurance philosophy, the Living Forward Reporting Principle, provides up-to-the-minute intelligence on what's happening now, while constantly keeping track of future opportunities. Follow IIR on: Facebook - Twitter - LinkedIn.
Industrial Info is tracking 98 active pharmaceutical intermediates projects across China, totaling more than $4.3 billion of investment. Subscribers to Industrial Info's Global Market Intelligence (GMI) Pharmaceutical & Biotech Project Database can click here for a list of related projects.
Click on the image at right for a heat map of China's active pharmaceutical intermediates projects, from Industrial Info's Geolocator tool.Zhejiang Jiuzhou Pharmaceutical Company Limited accounts for more investment than any other company, with more than $246 million from two projects. Most of China's pharmaceutical intermediates manufacturing companies are located in the Jiangsu and Zhejiang provinces, particularly in the cities of Taizhou and Jintan, due to preferential tax policies and support from local civic leaders.
Other key players in the China intermediates market include Zhejiang Longsheng Group Company Limited, Nantong Acetic Acid Chemical Company Limited, Apeloa Pharmaceutical Company Limited, Shandong Sinobioway Biomedicine Company Limited and Zhe Jiang Hua Hai Pharmaceutical Company Limited.
Industrial Info Resources (IIR), with global headquarters in Sugar Land, Texas, six offices in North America and 12 international offices, is the leading provider of global market intelligence specializing in the industrial process, heavy manufacturing and energy markets. Industrial Info's quality-assurance philosophy, the Living Forward Reporting Principle, provides up-to-the-minute intelligence on what's happening now, while constantly keeping track of future opportunities. Follow IIR on: Facebook - Twitter - LinkedIn.
